Changes in circulating filarial antigen (CFA) prevalence and levels at years 1, 2, and 3 following the start of mass drug administration, with treatment given semiannually (2x/yr)... by Michael C. Payne (2664379)

Parapapillary choroidal microvasculature in eyes with myopia and glaucoma (inner/outer whole annulus PPCMv densities=  0.092/0.069), glaucoma without myopia (0.092/0.071), and myop... by Yanin Suwan (4752099)

BFD2 aggravates the inflammatory response to <i>Toxoplasma gondii</i> infection. by Xiaocheng Zhang (3140460)

Age-standardized prevalence rates of gynecological diseases across 21 GBD regions, by SDI, from 1990 to 2021. by Xiaofeng He (2618752)

Conceptual framework to guide the study. by Resham B. Khatri (10949429)

“…From 2011 to 2022, there were increased institutional deliveries overall (47% to 81%) and CS within private HFs (30% to 51%), alongside a decreasing trend in the utilization of maternity incentives (87% to 78%). …”

Forest plot of the improvement in primary endpoints. by Jin-Min Gu (17915039)

Forest plot of inflammatory markers. by Jin-Min Gu (17915039)

Forest plot of the second endpoint of the clinical symptom improvement. by Jin-Min Gu (17915039)

Age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI. by Xiaofeng He (2618752)

The prevalence and absolute counts of peripheral blood Lymphocyte subsets. by Songyan Zou (11399489)

Prevalence and trends of gynecological diseases (GDs) among women of childbearing age, by age group and SDI. by Xiaofeng He (2618752)

Prevalence of gynecological diseases (GDs) among women of childbearing age in 2021, along with their changes from 1990 to 2021, and the contribution of each GD to the overall preva... by Xiaofeng He (2618752)

BFD2 mediates brain inflammation induced in the acute stage of <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)

Therapeutic efficacy of Clrn1 re-expression in Müller glia depends on expression level. by Hannah J. T. Nonarath (20861735)

“…<p>(a) Retinal images of 7 dpf wild-type (upper rows) and <i>clrn1</i>^<i>-/-</i> mutant (lower rows) zebrafish expressing different transgenes (column labels) raised in control lighting conditions (right) or treated from 5-7 dpf with 3500 lux for 48 hours (left, light stress). …”

Land-use change in Quetta from (a) 1992, (b) 2002, (c) 2013 and (d) 2022. by Naveed Ahmed (2433958)

“…It is evident from the results that barren land in Quetta increased in 2022, whereas build-up area significantly decreased, as shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0317342#pone.0317342.g006" target="_blank">Fig 6</a>. …”

DataSheet1_Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation.ZIP by Jing Lu (120666)

“…Yet little is known about apoA-I ’s role in peritoneal dialysis. In this study, by analyzing PD patients (n = 81), we found that decreased apoA/HDL-C ratio is significantly associated with rapid decline in peritoneal function. …”

Development of hamstring strength throughout the LIST. by Dominic Michael Rasp (19959412)

Development of the limb symmetry index (LSI) over the course of the LIST. by Dominic Michael Rasp (19959412)